🇺🇸 FDA
Pipeline program

Quadrivalent influenza vaccine

GC3110A_P1/2a

Phase 2 mab completed

Quick answer

Quadrivalent influenza vaccine for Influenza is a Phase 2 program (mab) at Green Valley (Shanghai) Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Green Valley (Shanghai) Pharmaceuticals Co.,
Indication
Influenza
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials